Abstract
5-fluorouracil (5-Fu) is a chemotherapy drug commonly used in various types of cancers, including lung cancer. However, in order to decrease its side effects, the drug had to be loaded onto a nanocarrier. In this work, ZnO nanoparticles are prepared via sedimentation of Zn(OAc)2·2H2O in absolute ethanol and specified by some analytical techniques. Then, 5-fluorouracil molecules are loaded onto the surface of nanomaterial and loading/ release properties of the mentioned drug are investigated under in vitro conditions. After that, the electronic sensitivity and effectiveness of ZnO nanocluster bearing 5-fluorouracil were investigated theoretically with the B3LYP/wB97XD density functional theory (DFT). Theoretical parameters including band gap energy (Eg), molecular electrostatic potential (MEP), adsorption energy (Ead), density of electronic states, and global hardness (η) are also analyzed and compared. Furthermore, an MTT experiment was planned to investigate cytocompatibility of the drug-loaded material on the lung cancer cells A549. This study confirmed that drug-loaded material has a higher antiproliferative activity compared to free drug against A549 cancer cells.
Similar content being viewed by others
References
Y.F. Mustafa, N.A. Mohammed, A promising oral 5-Fluorouracil prodrug for lung tumor: Synthesis, characterization, and release. Biochem. Cell. Arch. 21, (2021)
P.H. Sugarbaker, After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. Surg. Oncol. 42, 101757 (2022)
Y. Qin, J. Xie, H. Wang, Efficacy and safety of combined use of docetaxelgemcitabine chemotherapy and 5-fluorouracil targeted therapy in the treatment of advanced non-small cell lung cancer. Trop. J. Pharm. Res. 21(7), 1523–1529 (2022)
A.A. Valencia-Lazcano, D. Hassan, M. Pourmadadi, R. Behzadmehr, A. Rahdar, D.I. Medina, A.M. Díez-Pascual, 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy. Eur. J. Med. Chem. 246, 114995 (2023)
T.T. Dongsar, T.S. Dongsar, N. Gupta, W.H. Almalki, A. Sahebkar, P. Kesharwani, Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy. J. Drug Deliv. Sci. Technol. 104371 (2023)
Y. Zhihong, Y. Ye, A. Pejhan, A.H. Nasr, N. Nourbakhsh, R. Tayebee, A theoretical study on the pure and doped ZnO nanoclusters as effective nanobiosensors for 5-fluorouracil anticancer drug adsorption. Appl. Organomet. Chem. 34(4), e5534 (2020)
E. Shakerzadeh, K.K. Zborowski, E.C. Anota, M.T. Nguyen, Pristine and alkali and alkaline Earth metals encapsulated B36N36 nanoclusters as prospective delivery agents and detectors for 5-fluorouracil anticancer drug. Appl. Organomet. Chem. 36(7), e6721 (2022)
S.A. Thomas, Z. Grami, S. Mehta, K. Patel, Adverse effects of 5-fluorouracil: focus on rare side effects. Cancer Cell Microenviron. 3(2), e1266 (2016)
K. Suwannakot, N. Sritawan, R. Prajit, A. Aranarochana, A. Sirichoat, W. Pannangrong, P. Wigmore, J.U. Welbat, Melatonin protects against the side-effects of 5-fluorouracil on hippocampal neurogenesis and ameliorates antioxidant activity in an adult rat hippocampus and prefrontal cortex. Antioxidants. 10(4), 615 (2021)
G. Naren, J. Guo, Q. Bai, N. Fan, B. Nashun, Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans. Expert Rev. Mol. Med. 24, e9 (2022)
S.M. Asil, J. Ahlawat, G.G. Barroso, M. Narayan, Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomater. Sci. 8(15), 4109–4128 (2020)
X. Zheng, P. Zhang, Z. Fu, S. Meng, L. Dai, H. Yang, Applications of nanomaterials in tissue engineering. RSC Adv. 11(31), 19041–19058 (2021)
T.A. Singh, J. Das, P.C. Sil, Zinc oxide nanoparticles: A comprehensive review on its synthesis, anticancer and drug delivery applications as well as health risks. Adv. Coll. Interface. Sci. 286, 102317 (2020)
S. Anjum, M. Hashim, S.A. Malik, M. Khan, J.M. Lorenzo, B.H. Abbasi, C. Hano, Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment. Cancers 13(18), 4570 (2021)
V. Puspasari, A. Ridhova, A. Hermawan, M.I. Amal, M.M. Khan, ZnO-based antimicrobial coatings for biomedical applications. Bioprocess Biosyst. Eng. 45(9), 1421–1445 (2022)
P. Sathishkumar, Z. Li, R. Govindan, R. Jayakumar, C. Wang, F.L. Gu, Zinc oxide-quercetin nanocomposite as a smart nano-drug delivery system: molecular-level interaction studies. Appl. Surf. Sci. 536, 147741 (2021)
A. Dakhlaoui, M. Jendoubi, L.S. Smiri, A. Kanaev, N. Jouini, Synthesis, characterization and optical properties of ZnO nanoparticles with controlled size and morphology. J. Cryst. Growth 311(16), 3989–3996 (2009)
Z. Liu, Z. Yu, L. Zhang, R. Tayebee, S. Pourmojahed, E.E. Shahri, X. Chen, Studying loading of 5-fluorouracil onto the surface of gold–silver nanocomposite utilizing DLS and UV–Vis spectroscopy. Chem. Papers 1–11 (2023)
R. Tayebee, F. Javadi, G. Argi, Easy single-step preparation of ZnO nano-particles by sedimentation method and studying their catalytic performance in the synthesis of 2-aminothiophenes via Gewald reaction. J. Mol. Catal. A Chem. 368, 16–23 (2013)
G. Acharya, K. Park, Mechanisms of controlled drug release from drug-eluting stents. Adv. Drug Deliv. Rev. 58(3), 387–401 (2006)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflict of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, Y., Zhu, J., Zhao, N. et al. ZnO as a promising nanocarrier for efficient delivery of 5-fluorouracil anticancer drug. J IRAN CHEM SOC 20, 2871–2877 (2023). https://doi.org/10.1007/s13738-023-02883-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-023-02883-x